Arrowhead Pharmaceuticals Inc
ARWR
ISIN US04280A1007 / Valor 32193461
Arrowhead Pharmaceuticals Inc
UMushroom community rating:
About company
Arrowhead Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development of innovative drugs. The company focuses on leveraging its proprietary RNA interference (RNAi) technology to silence genes that cause diseases. A specific example of their work includes the clinical study of ARO-RAGE, a therapeutic candidate aimed at treating inflammatory lung diseases. This study is designed to assess the safety, tolerability, and pharmacokinetics of ARO-RAGE in both normal healthy volunteers and participants with inflammatory lung disease, indicating Arrowhead's commitment to addressing unmet medical needs in the respiratory disease area. The study is structured in two parts, with the initial phase testing the drug on healthy volunteers and the subsequent phase on patients with the targeted condition, showcasing the company's methodical approach to drug development and its focus on RNAi technology as a basis for its therapeutic innovations.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
2672 M
Market cap (USD)
306,634
Daily traded volume (Shares)
21.5 / 20.405
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
